Clinical Trials Directory

Trials / Unknown

UnknownNCT02199275

Effect of General Anesthesia on Enterocyte Damage

Impact of General Anesthesia on Enterocyte Damage

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Centre Hospitalier Universitaire de Besancon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

During non urgent surgery, general anesthesia might induce enterocyte damage. I-FABP is a performant biomarker of enterocyte damage. We aimed to study whether patient ongoing general anesthesia for non-urgent surgery have an elevation of plasma I-FABP concentration.

Detailed description

Inclusion criteria * Indication of non-urgent surgery * General anesthesia protocol using propofol and remifentanyl * One half of the patients have a history of ischemic arteriopathy * One half of the patients have no history of ischemic arteriopathy Exclusion criteria * Age \< 18 years old * Pregnant Primary objective Is there a significant elevation of I-FABP between the pre-anesthesic period and 11 minutes after induction of general anesthesia ? Secondary objectives 1. Is I-FABP elevation higher among patients with history of patent arteriopathy ? 2. Is I-FABP elevation higher among patients presenting with hypotension during anesthesia ?

Conditions

Timeline

Start date
2013-08-01
Primary completion
2014-08-01
Completion
2014-08-01
First posted
2014-07-24
Last updated
2014-07-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02199275. Inclusion in this directory is not an endorsement.